Assessing Aerosol Performance of a Dry Powder Carrier Formulation with Increasing Doses Using a Novel Inhaler
- 28 January 2019
- journal article
- research article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 20 (3) , 94
Abstract
This study aims to investigate the implications of loaded formulation mass on aerosol performance using a reservoir novel dry powder inhaler containing a custom dosing cup to deliver carrier-based...Keywords
This publication has 31 references indexed in Scilit:
- Limitations of high dose carrier based formulationsInternational Journal of Pharmaceutics, 2018
- Inhaled Laninamivir Octanoate as Prophylaxis for Influenza in ChildrenPediatrics, 2016
- The Delivery of High-Dose Dry Powder Antibiotics by a Low-Cost Generic InhalerThe AAPS Journal, 2016
- Colobreathe® for the Treatment of Cystic Fibrosis-Associated Pulmonary InfectionsPulmonary Therapy, 2015
- Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed DesignAnnals of Biomedical Engineering, 2015
- The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ familyEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- Effects of formulation and operating variables on Zanamivir dry powder inhalation characteristics and aerosolization performanceDrug Delivery, 2014
- How can we bring high drug doses to the lung?European Journal of Pharmaceutics and Biopharmaceutics, 2014
- Tobramycin administered by the TOBI® Podhaler® for persons with cystic fibrosis: a reviewMedical Devices: Evidence and Research, 2011
- The Cohesive-Adhesive Balances in Dry Powder Inhaler Formulations I: Direct Quantification by Atomic Force MicroscopyPharmaceutical Research, 2004